Skip to main content

Daily Ards Research Analysis

3 papers

Three ARDS studies stood out today: a systematic review from Sub-Saharan Africa exposes large diagnostic and resource gaps with high, variable mortality; a prospective cohort shows driving pressure, not mechanical power, independently predicts mortality; and a multicenter neonatal cohort identifies gestational-age–dependent interactions with high-frequency ventilation and inhaled nitric oxide that increase mortality risk.

Summary

Three ARDS studies stood out today: a systematic review from Sub-Saharan Africa exposes large diagnostic and resource gaps with high, variable mortality; a prospective cohort shows driving pressure, not mechanical power, independently predicts mortality; and a multicenter neonatal cohort identifies gestational-age–dependent interactions with high-frequency ventilation and inhaled nitric oxide that increase mortality risk.

Research Themes

  • Resource-limited ARDS care and diagnostic adaptation
  • Ventilator physiology and prognostication in ARDS
  • Neonatal ARDS risk stratification and treatment interactions

Selected Articles

1. Epidemiology, management and outcome of acute respiratory distress syndrome in Sub-Saharan Africa: a systematic review.

67Level IISystematic ReviewJRSM open · 2025PMID: 41209376

This systematic review across 11 Sub-Saharan African countries found highly variable ARDS prevalence, frequent use of the Kigali modification due to limited diagnostics, constrained access to invasive ventilation, and mortality ranging from 22% to 77%. The dominant etiologies were pneumonia, sepsis, and trauma, with substantial contributions from HIV, TB, and malaria.

Impact: It provides the first consolidated view of ARDS burden, diagnostics, and management gaps in SSA, guiding context-appropriate policies and capacity building.

Clinical Implications: Adopt context-adapted diagnostic criteria (e.g., Kigali modification), expand access to oxygen therapy and invasive ventilation, and prioritize critical care training and infrastructure to reduce mortality.

Key Findings

  • ARDS prevalence across SSA ranged from 2.4% to 100% among included studies.
  • The Kigali modification of the Berlin criteria was most commonly used due to limited chest radiography and arterial blood gases.
  • Pneumonia, sepsis, and trauma were predominant causes; HIV, tuberculosis, and malaria contributed substantially.
  • Access to invasive mechanical ventilation was limited; mortality ranged from 22% to 77%.

Methodological Strengths

  • Systematic review across 11 countries with explicit focus on resource-limited settings
  • Contemporary timeframe (2000–2024) capturing evolving ARDS definitions and practices

Limitations

  • High heterogeneity in definitions, diagnostics, and reporting across studies
  • Limited number of studies and potential publication bias reduce generalizability

Future Directions: Establish prospective multicenter registries in SSA, validate context-adapted diagnostic criteria, and test scalable interventions (oxygen systems, training, ventilation protocols) to reduce mortality.

2. Mechanical Power and its Components vs Driving Pressure for Predicting Mortality in Acute Respiratory Distress Syndrome: A Prospective Observational Study.

65.5Level IIICohortIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025PMID: 41210536

In 137 ARDS patients, mechanical power was higher among non-survivors but lost independent association with mortality after adjustment, whereas driving pressure remained an independent predictor. Elastic dynamic power contributed most to elevated mechanical power.

Impact: It clarifies conflicting evidence by demonstrating that driving pressure, not mechanical power, independently predicts mortality in ARDS, directly informing ventilator management.

Clinical Implications: Prioritize minimizing driving pressure during lung-protective ventilation; use mechanical power and its components as contextual metrics rather than primary prognostic targets.

Key Findings

  • Among 137 ARDS patients, 53.3% were non-survivors.
  • Median mechanical power was higher in non-survivors (29 J/min) vs survivors (24 J/min).
  • After adjustment, mechanical power was not an independent predictor of mortality; driving pressure was.
  • Elastic dynamic power was the dominant component contributing to high mechanical power.

Methodological Strengths

  • Prospective observational design with predefined physiologic variables
  • Multivariable adjustment assessing MP, its components, and driving pressure alongside clinical factors

Limitations

  • Single-center study limits generalizability
  • Moderate sample size; no interventional comparison or external validation

Future Directions: Conduct multicenter studies to validate driving pressure thresholds and integrate DP into ventilator management protocols and decision-support tools.

3. Risk factors for mortality in neonatal ARDS: a multicenter retrospective cohort study in China.

57.5Level IIICohortFrontiers of medicine · 2025PMID: 41212482

In a multicenter retrospective cohort of neonates with ARDS requiring IMV within 72 hours of birth, LASSO-selected variables (iNO, HFV, GA, IMV duration) were associated with mortality. Higher gestational age, receipt of iNO, and HFV were linked to increased mortality; GA ≥38.785 weeks and IMV duration <117 hours marked higher risk, with significant interactions between iNO–IMV and HFV–GA.

Impact: It challenges assumptions that greater gestational maturity confers protection by identifying a GA-dependent risk increase when HFV and iNO are used, refining neonatal ARDS risk stratification.

Clinical Implications: When considering HFV and iNO in neonates with higher GA, clinicians should recognize potential increased mortality risk, intensify monitoring, and weigh alternative strategies while validating in prospective studies.

Key Findings

  • Four variables (iNO, HFV, GA, IMV duration) were identified by LASSO and associated with mortality in Cox models.
  • Higher GA, receiving iNO, and undergoing HFV were associated with higher mortality on Kaplan–Meier analysis.
  • Restricted cubic spline indicated GA ≥38.785 weeks and IMV duration <117 hours corresponded to significantly increased mortality risk.
  • Significant interactions were observed between iNO and IMV duration, and between HFV and GA.

Methodological Strengths

  • Multicenter cohort with modern variable selection (LASSO) and Cox modeling
  • Use of restricted cubic splines and interaction analysis to characterize nonlinear and effect-modifying relationships

Limitations

  • Retrospective design with potential confounding by indication for HFV and iNO
  • Sample size and external generalizability not specified in the abstract; potential center-level practice variability

Future Directions: Prospective validation and randomized or pragmatic trials to test HFV and iNO strategies stratified by gestational age and IMV duration thresholds.